Last 7 days
-6.8%
Last 30 days
-16.5%
Last 90 days
-31.5%
Trailing 12 Months
-83.0%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 125.3B | 26.3B | -2.75% | 3.76% | 19.12 | 4.76 | 1.32% | 11.18% |
GILD | 99.6B | 27.3B | -8.96% | 41.01% | 21.68 | 3.65 | -0.09% | -26.23% |
MRNA | 58.4B | 19.3B | -12.76% | 1.00% | 6.99 | 3.03 | 4.29% | -31.47% |
BIIB | 38.3B | 10.2B | -9.67% | 32.94% | 12.57 | 3.76 | -7.36% | 95.80% |
MID-CAP | ||||||||
NBIX | 9.1B | 1.5B | -9.09% | 3.35% | 58.87 | 6.11 | 31.34% | 72.43% |
DNLI | 3.2B | 108.5M | -21.10% | -19.55% | -9.78 | 29.38 | 122.90% | -12.19% |
BEAM | 2.5B | 60.9M | -18.47% | -36.46% | -8.76 | 41.55 | 17.51% | 22.00% |
BBIO | 2.1B | 107.9M | 22.95% | 67.45% | -4.29 | 19.27 | 54.84% | 17.36% |
SMALL-CAP | ||||||||
RCUS | 1.2B | 112.0M | -14.86% | -46.41% | -4.63 | 11.04 | -70.76% | -603.77% |
REPL | 1.1B | 7.0M | -22.18% | 24.65% | -7.11 | 158.97 | 131.81% | -45.39% |
FATE | 541.9M | 96.3M | -12.99% | -82.24% | -1.92 | 5.63 | 72.44% | -32.79% |
NVAX | 513.7M | 2.0B | -39.67% | -92.01% | -0.78 | 0.26 | 72.89% | 62.27% |
SGMO | 355.3M | 111.3M | -30.55% | -58.78% | -1.85 | 3.19 | 0.54% | -7.86% |
VXRT | 101.4M | 159.0K | -16.47% | -82.96% | -0.97 | 637.62 | -86.46% | -64.56% |
IBIO | 25.1M | - | 94.03% | -77.12% | -0.31 | 3.21 | 0.51% | -185.61% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -32.7% | 107,000 | 159,000 | 359,000 | 471,000 | 892,000 |
Operating Expenses | 6.4% | 114,694,000 | 107,823,000 | 95,848,000 | 82,488,000 | 73,644,000 |
S&GA Expenses | 2.4% | 29,386,000 | 28,693,000 | 26,775,000 | 22,604,000 | 21,890,000 |
R&D Expenses | 6.5% | 81,054,000 | 76,125,000 | 66,068,000 | 56,879,000 | 48,749,000 |
EBITDA | -12.7% | -99,422,000 | -88,233,000 | -75,132,000 | -66,155,000 | - |
EBITDA Margin | -154.4% | -625 | -245 | -159 | -74.16 | - |
Earnings Before Taxes | -3.0% | -107,691,000 | -104,535,000 | -92,804,000 | -79,475,000 | -70,363,000 |
EBT Margin | -154.3% | -657 | -258 | -168 | -78.88 | - |
Interest Expenses | - | 0.00 | - | - | - | - |
Net Income | -3.0% | -107,758,000 | -104,604,000 | -92,878,000 | -79,564,000 | -70,470,000 |
Net Income Margin | -154.3% | -657 | -258 | -168 | -79.00 | - |
Free Cahsflow | -1.2% | -88,156,000 | -87,104,000 | -74,241,000 | -64,989,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -12.2% | 154 | 175 | 181 | 200 | 221 |
Current Assets | -17.4% | 99.00 | 120 | 138 | 154 | 169 |
Cash Equivalents | -9.4% | 46.00 | 51.00 | 91.00 | 123 | 144 |
Net PPE | 26.9% | 16.00 | 12.00 | 9.00 | 8.00 | 7.00 |
Goodwill | 0% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Liabilities | -18.4% | 43.00 | 53.00 | 38.00 | 34.00 | 34.00 |
Current Liabilities | -17.6% | 18.00 | 22.00 | 16.00 | 11.00 | 11.00 |
Shareholder's Equity | -9.6% | 111 | 122 | 143 | 166 | 188 |
Retained Earnings | -7.9% | -327 | -303 | -273 | -244 | -219 |
Additional Paid-In Capital | 2.8% | 438 | 426 | 417 | 411 | 407 |
Accumulated Depreciation | 23.0% | 3.00 | 2.00 | 2.00 | 1.00 | - |
Shares Outstanding | 4.6% | 134 | 128 | 126 | 126 | 126 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -16.4% | -94.78 | -81.44 | -81.09 | -68.35 | -59.83 |
Share Based Compensation | 3.7% | 14.00 | 13.00 | 12.00 | 11.00 | 9.00 |
Cashflow From Investing | 54.0% | -20.41 | -44.39 | -17.73 | -24.81 | -49.10 |
Cashflow From Financing | 86.3% | 17.00 | 9.00 | 25.00 | 59.00 | 126 |
100%
100%
100%
Y-axis is the maximum loss one would have experienced if Vaxart was unfortunately bought at previous high price.
-34.5%
-19.5%
FIve years rolling returns for Vaxart.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.04 | -17,342 | 13,658 | -% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -56,479 | 44,521 | -% |
2023-02-24 | NATIXIS | sold off | -100 | -42,000 | - | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -20,000 | - | -% |
2023-02-16 | GHP Investment Advisors, Inc. | unchanged | - | 154 | 154 | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | unchanged | - | -3,550 | 1,450 | -% |
2023-02-15 | JANE STREET GROUP, LLC | added | 389 | 454,952 | 847,952 | -% |
2023-02-15 | CI Private Wealth, LLC | new | - | 17,608 | 17,608 | -% |
2023-02-15 | Metropolitan Life Insurance Co/NY | added | 7.11 | -8,255 | 7,745 | -% |
2023-02-15 | Steward Partners Investment Advisory, LLC | reduced | -20.00 | -2,463 | 1,537 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 5.35% | 7,019,507 | SC 13G | |
Feb 01, 2023 | blackrock inc. | 6.7% | 8,858,225 | SC 13G/A | |
Jan 10, 2023 | state street corp | 1.83% | 2,398,264 | SC 13G/A | |
Mar 10, 2022 | state street corp | 10.39% | 13,072,021 | SC 13G/A | |
Feb 11, 2022 | state street corp | 8.91% | 11,187,642 | SC 13G/A | |
Feb 07, 2022 | blackrock inc. | 6.7% | 8,452,420 | SC 13G | |
Feb 11, 2021 | state street corp | 8.63% | 9,444,967 | SC 13G | |
Jun 09, 2020 | armistice capital, llc | 19.99% | 16,785,583 | SC 13D/A | |
May 27, 2020 | armistice capital, llc | 11.3% | 8,400,000 | SC 13D/A | |
May 18, 2020 | armistice capital, llc | 14.0% | 10,350,000 | SC 13D/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% |
Current Inflation | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% |
Very High Inflation | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% | 0.23 -70.89% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 16, 2023 | 8-K | Current Report | |
Mar 15, 2023 | 10-K | Annual Report | |
Feb 09, 2023 | SC 13G | Major Ownership Report | |
Feb 01, 2023 | SC 13G/A | Major Ownership Report | |
Jan 10, 2023 | SC 13G/A | Major Ownership Report | |
Dec 30, 2022 | 4 | Insider Trading | |
Dec 30, 2022 | 3 | Insider Trading | |
Dec 28, 2022 | 4 | Insider Trading | |
Dec 19, 2022 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-12-28 | Watson W. Mark | bought | 15,140 | 0.757 | 20,000 | - |
2022-12-16 | Lee Phillip E | acquired | - | - | 206,250 | chief financial officer |
2022-08-25 | HERON ELAINE J | acquired | - | - | 14,750 | - |
2022-08-24 | Yedid Robert A. | gifted | - | - | -26,240 | - |
2022-08-19 | Yedid Robert A. | acquired | 24,774 | 0.944146 | 26,240 | - |
2022-08-04 | Wheadon David E. | acquired | - | - | 7,375 | - |
2022-08-04 | Yedid Robert A. | acquired | - | - | 7,375 | - |
2022-08-04 | Watson W. Mark | acquired | - | - | 14,750 | - |
2022-08-04 | Cherrington Julie M | acquired | - | - | 6,217 | - |
2022-08-04 | Davis Todd C | acquired | - | - | 7,375 | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue from Contract with Customer, Including Assessed Tax | $ 107 | $ 892 |
Operating expenses: | ||
Research and development | 81,054 | 48,749 |
General and administrative | 29,386 | 21,890 |
Impairment of intangible assets | 4,254 | 3,005 |
Total operating expenses | 114,694 | 73,644 |
Operating loss | (114,587) | (72,752) |
Other income (expense): | ||
Interest income | 1,247 | 81 |
Non-cash interest expense related to sale of future royalties | (1,305) | (1,480) |
Gain on remeasurement of future royalty liability | 6,960 | 3,789 |
Foreign exchange loss, net | (6) | (1) |
Loss before income taxes | (107,691) | (70,363) |
Provision for income taxes | 67 | 107 |
Net loss | $ (107,758) | $ (70,470) |
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | $ (0.84) | $ (0.58) |
Shares used to compute net loss per share, basic and diluted (in shares) | 127,683,813 | 121,453,723 |
Comprehensive loss: | ||
Net loss | $ (107,758) | $ (70,470) |
Unrealized loss on available-for-sale investments, net of tax | (225) | (74) |
Comprehensive loss | (107,983) | (70,544) |
Customer Service Contracts [Member] | ||
Revenue from Contract with Customer, Including Assessed Tax | 0 | 13 |
Non Cash Royalty Revenue [Member] | ||
Revenue from Contract with Customer, Including Assessed Tax | $ 107 | $ 879 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash, cash equivalents and restricted cash | $ 46,013 | $ 143,745 |
Short-term investments | 49,704 | 22,742 |
Accounts receivable | 20 | 71 |
Prepaid expenses and other current assets | 3,714 | 2,609 |
Total current assets | 99,451 | 169,167 |
Long-term investments | 0 | 16,210 |
Property and equipment, net | 15,585 | 6,601 |
Right-of-use assets, net | 25,715 | 13,168 |
Intangible assets, net | 5,020 | 10,624 |
Goodwill | 4,508 | 4,508 |
Other long-term assets | 3,568 | 890 |
Total assets | 153,847 | 221,168 |
Current liabilities: | ||
Accounts payable | 5,514 | 3,872 |
Deferred grant revenue | 2,000 | 0 |
Other accrued current liabilities | 8,084 | 5,064 |
Current portion of operating lease liability | 2,228 | 1,011 |
Current portion of liability related to sale of future royalties | 95 | 836 |
Total current liabilities | 17,921 | 10,783 |
Operating lease liability, net of current portion | 19,477 | 11,997 |
Liability related to sale of future royalties, net of current portion | 5,621 | 10,686 |
Other long-term liabilities | 231 | 171 |
Total liabilities | 43,250 | 33,637 |
Commitments and contingencies (Note 9) | ||
Stockholders’ equity: | ||
Preferred Stock: $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of December 31, 2022 or 2021 | 0 | 0 |
Common Stock: $0.0001 par value; 250,000,000 and 150,000,000 shares authorized as of December 31, 2022 and 2021, respectively; 134,199,429 and 125,594,393 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 13 | 13 |
Additional paid-in capital | 437,992 | 406,943 |
Accumulated deficit | (327,109) | (219,351) |
Accumulated other comprehensive loss | (299) | (74) |
Total stockholders’ equity | 110,597 | 187,531 |
Total liabilities and stockholders’ equity | $ 153,847 | $ 221,168 |